To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: The U.K. Approves Copaxone (Glatiramer Acetate) For Relapsing-remitting Multiple Sclerosis URL: http://www.pslgroup.com/dg/1DD00E.htm Doctor's Guide August 14, 2000
JERUSALEM, ISRAEL -- August 14, 2000 -- Teva Pharmaceutical Industries, Ltd., announced that Copaxone® (glatiramer acetate for injection) was approved for marketing in the U.K. This is the first approval in a major European market and enables Teva to file for approval all over the E.U. under the mutual recognition procedure. Teva plans to launch Copaxone in the U.K. market in the beginning of the fourth quarter of this year. Copaxone is indicated for reduction in frequency of relapses in relapsing-remitting multiple sclerosis. Eli Hurvitz, President and Chief Executive Officer commented: "We are excited to have received this approval and even more with the opportunity it represents for the rest of the European market." Teva is currently preparing the filing under the European Mutual Recognition Procedure to make Copaxone available in the remainder of the European Union. The U.K. has agreed to act as the reference member state. The successful completion of this procedure is expected to enable Teva to launch Copaxone in the E.U. around mid 2001. Related Links: Copaxone (glatiramer acetate) and Teva Pharmaceutical Industries, Ltd. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.